Community Programs for Clinical Research on AIDS: Difference between revisions

Revision as of 19:20, 7 July 2019

Revision as of 14:59, 19 July 2019

Line 17:

An antiretroviral medication self-reporting questionnaire was developed by the programme.<ref>{{cite journal |url=http://cid.oxfordjournals.org/content/34/8/1115.full |title=The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus—Infected Persons in Clinical Trials |first1=Sharon |last1=Mannheimer |first2=Gerald |last2=Friedland |first3=John |last3=Matts |first4=Carroll |last4=Child |first5=Margaret |last5=Chesney |journal=Clinical Infectious Diseases |year=2002 |volume=34 |issue=8 |pages=1115–21 |doi=10.1086/339074 |pmid=11915001}}</ref>

The programme organised the 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial: a large, long-term, randomised, prospective comparison of three different antiretroviral strategies in [[highly active antiretroviral therapy]]-naïve, HIV-1-infected persons.<ref>{{cite journal |url=http://www.sciencedirect.com/science/article/pii/S0197245601001118 |title=The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial |last1=MacArthur |first1=RD |last2=Chen |first2=L |last3=Mayers |first3=DL |last4=Besch |first4=CL |last5=Novak |first5=R |last6=van den Berg-Wolf |first6=M |last7=Yurik |first7=T |last8=Peng |first8=G |last9=Schmetter |first9=B |last10=Brizz |first10=B |last11=Abrams |first11=D |journal=Control Clin Trials |date=April 2001 |volume=22 |issue=2 |pages=176–90 |doi=10.1016/S0197-2456(01)00111-8|pmid=11306155 }}</ref>

==References==